XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.265
+0.005 (0.40%)
Nov 21, 2024, 3:10 PM EST - Market closed

XORTX Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Jan '22 Dec '20 Dec '19 2018 - 2015
Net Income
-0.74-2.16-7.72-1.58-1.28-0.63
Upgrade
Depreciation & Amortization
0.120.140.060.010.020.02
Upgrade
Asset Writedown & Restructuring Costs
----0.06-
Upgrade
Stock-Based Compensation
0.140.120.490.460.290.03
Upgrade
Other Operating Activities
-3.59-3.66-3.26-2.61-0.180.04
Upgrade
Change in Accounts Receivable
0.060.02-0.04-0.03-0.01
Upgrade
Change in Accounts Payable
-0.23-1.190.89-0.260.410.35
Upgrade
Change in Other Net Operating Assets
0.150.140.62-0.79-0.04-0.07
Upgrade
Operating Cash Flow
-4.09-6.58-8.96-4.8-0.73-0.25
Upgrade
Capital Expenditures
-0-0-0.02---
Upgrade
Sale (Purchase) of Intangibles
-0.04-0.04-0.03-0.03-0.01-0.01
Upgrade
Investing Cash Flow
-0.04-0.05-0.05-0.03-0.01-0.01
Upgrade
Long-Term Debt Repaid
--0.07-0.02---
Upgrade
Net Debt Issued (Repaid)
-0.06-0.07-0.02---
Upgrade
Issuance of Common Stock
2.020520.070.90.07
Upgrade
Other Financing Activities
-0.59-0.3-0.27-0.7-0.04-0.01
Upgrade
Financing Cash Flow
1.36-0.364.7119.370.860.06
Upgrade
Foreign Exchange Rate Adjustments
0.010-0.140.2--
Upgrade
Net Cash Flow
-2.77-6.99-4.4414.740.11-0.2
Upgrade
Free Cash Flow
-4.09-6.59-8.98-4.8-0.73-0.25
Upgrade
Free Cash Flow Per Share
-1.60-3.32-6.07-4.39-0.98-0.42
Upgrade
Levered Free Cash Flow
-1.71-4.2-3.8-0.83-1.740.03
Upgrade
Unlevered Free Cash Flow
-1.71-4.2-3.8-0.82-1.730.05
Upgrade
Change in Net Working Capital
0.151.32-1.47-0.181.34-0.31
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.